ABSTRACT MicroRNAs (miRNAs) are key gene regulators in all living organisms. They play an important role in various diseases including breast cancer (BC). Mutations within MIR27a gene have been linked with various types of cancers including breast cancer. Several tools are being used to identify potential targets for crucial miRNA genes. In the present study, online target prediction tools were used to investigate target genes that may be regulated by the mature form of MIR27a (hsa-mir-27a-3p and has-mir-27a-5p). A total of 52 target genes were found for hsa-mir-27a while for hsa-mir-27a-5p determined 45 targets. These target genes were further explored for their potential role in BC. It was found that the target genes are involved in vital biological processes in cancer progression and development. In conclusion, MIR27a may regulate several genes that are vital for BC development and progression. MIR27a may act as a promising new biomarker for anti-breast cancer therapy.
INTRODUCTION
MicroRNAs (miRNAs) are small, highly conserved noncoding short (19-24 nt) RNA molecules that control gene expression post-transcriptionally, either by degradation of target mRNAs or by inhibition of protein translation. It is already known that miRNAs have a significant role in crucial biological pathways (Oliveto et al. 2017) More than fifty percent of all genes in the human genome are known to be regulated by miRNAs (Keller et al. 2014) . Recently it is shown that abnormal expression of miRNAs is related to a broad range of human diseases (Chen et al. 2018; Li and Kowdley 2012) . A large number of miRNAs have been discovered by cloning and size-fractionated RNA techniques. The researchers' previous studies have shown altered expression profile of selected miRNA in caloric metabolism and gastric cancer by using whole genome miRNA profiling studies using blood samples from human and related knockout mouse models (Shah et al. 2013; Shah et al. 2012; Shah et al. 2011) . MIR27a is thought to be an oncomir promoting tumor growth and metastasis. It has been reported to be a marker for breast cancer progression and patient survival (Zhao et al. 2016) . MiR-27a is involved in the modulation of growth, angiogenesis and metastasis of BC and gastric cancer cells (Ding et al. 2017; Zhou et al. 2016a; Tang et al. 2014) . Targets genes of the majority of the miRNA are not known, but the predicted limit is from a single to hundreds of genes for a certain miRN As, which is based on target estimation by applying an array of bioinformatics methods. The biogenesis of miRNAs is a highly regulated process, and alteration in their regulation is linked with many diseases in human (Chen et al. 2018; Ding et al. 2017; Ha and Kim 2014) . Expression of miRNAs is tissue-specific and also influenced by different developmental stages. Hence, miRNAs exhibiting abnormal expression levels in the situation of certain diseases are of great importance as therapeutic targets. As only a limited regulatory target is known, predicting and validating miRNA targets is one of the major hurdles in understanding miRNA biology. Due to diversity in miRNAs and difficulty in experimental identification of target genes, the specific function of most miRNAs is not known. It is necessary to find their target mRNAs to explore their post-transcriptional regulating properties and associations for ailments and diagnostics. Bioinformatics tools were used to predict target mRNAs for MIR27a.
METHODOLOGY

Target Prediction
Mir-27a was selected based on its curial role in the modulation of breast cancer. Matured sequences of MIR27a are hsa-miR-27a-5p (MI-MAT0004501) AGGGCUUAGCUGCUUGUGAG-CA and hsa-miR-27a-3p (MIMAT0000084) UU-CACAGUGGCUAAGUUCCGC. Twelve different target prediction tools were used for identification of target messenger RNAs for matured miRNAs of MIR27a. The prediction tools were selected on the basis of their availability on a single site (MirWalk 2.0) which reduced the amount of generated data by selection of filters. The target prediction tools used were Mirwalk, Microt4, Miranda, mirbridge, miRDB, miRMap, MiRNAMap, Pictar2, PITA, RNA22, RNAhybrid, and TargetScan. The predicted target genes were filtered based on the number of hits received and only those target genes were selected that were predicted by at least six target prediction tools.
Functions of the Predicted Target Genes
The filtered genes were enlisted, and previously published literature was searched for finding functions that may be associated with cancer, especially breast cancer. The data were searched using the keywords. Gene name and breast cancer/Gene name expression in breast cancer patients.
Grouping of Genes on the Basis of their Reported Activity in Cancer
The predicted genes were divided into groups as follows. Groups including all those predicted genes, which have been validated to be overexpressed or suppressed in different research studies in breast cancer with few from other human cancer such as hepatocellular carcinoma. Differentially expressed genes, genes involved in cancer progression, genes promoting tumorigenesis, genes involved in chromatin remodeling, cell migration inhibitors, tumor suppressors and cell proliferation promoters (Table 1) .
Finding Gene Networks
The association of the predicted genes with one another was found by using gene MANIA (Multiple Association Network Integration Algorithm). Gene MANIA is quick and accurate and does not rely on a pre-specified association network (Mostafavi et al. 2008 ). The gene MA-NIA attributes were set as co-expression 20/235, co-localization 4/4, genetic interactions 10/10, pathway 6/6, physical interaction 244/244, predicted 42/42, and shared protein domains 2/2. Interactions were found among all the predicted genes, predicted targets of has-mir-27a-3p, hsamir-27-5p, overexpressed genes and down-regulated genes.
RESULTS
Predicted Target Identification for hsa-mir27a-3p and hsa-mir-27a-5p and their Potential Role in Breast Cancer Progression
Target genes for the matured sequences of MIR27a (hsa-mir-27a-3p and hsa-mir-27a-5p) were investigated at the 3'-UTR of the mRNA of the target genes using bioinformatics tools. After filtering the results, 51 target genes were obtained for hsa-mir-27a-3p. Out of these genes, 40 are associated with cancer (Table 2) and 34 Highly expressed in breast cancer NCBI (Monni et al. 2001; Li et al. 2002) 
PPP1CC
Interacts with BRCA1 expressions ( Frequently upregulated in pancreatic and lung cancers (Kimura et al. 2016 ). CKAP4 expression was much higher in HCC tumor tissues compared with adjacent normal tissues and its expression was significantly correlated with tumor size (Li et al. 2014 ) SOWAHA Overexpression is associated with breast cancer cell proliferation (Imaoka et al. 2014) 
MAGI3
Promotes the malignant transformation of human mammary epithelial cells (Ni and genes for hsa-mir-27a-5p were associated with cancer ( Of these genes, nine are involved in cancer progression while eight genes act as tumor promoters. Six genes affect spindle fibers orientation and chromatin remodeling. Eight of them inhibit the migration of cancer cells. Fifteen are reportedly involved in the inhibition of tumor growth and development. Furthermore, eight genes were found to positively affect the proliferation of cancerous cells. Co-expression, pathway, co-localization, similar domain, and genetic interactions were investigated.
Deregulated Genes Interactions
For the overexpressed genes, there was 63.65 percent co-expression, 34.09 percent involvement in pathways, 1.14 percent co-localization and 1.14 percent genetic interactions. The overexpressed genes were found to have high similarity index of expression across different conditions. For down-regulated genes no significant association was found, co-expression 73.23 percent, predicted 15.84 percent, pathway 10.34 percent, genetic interactions 0.37 percent, and co-localization 0.22 percent. When all the deregulated genes were compared it was observed that they are related by having a 73.23 percent of similar expression (Table 4) .
hsa-mir27a-3p Target Predicted Genes Network
Interaction among the predicted genes was found with the help of gene MANIA online tools. Search conditions were set according to the following default arrangement. Co-expression 20/ 235, co-localization 4/4, genetic interactions 10/ 10, pathway 6/6, physical interaction 244/244, predicted 42/42 and shared protein domains 2/2. Co-expression shows that the genes are expressed together across different experimental conditions; Co-localization refers to the fact that the genes are expressed inside the same tissue or location; Pathways interaction means the protein of the genes are involved in the same reaction in a common pathway; Predicted are functions of the orthologous genes interaction obtained from a different organism; Genetic interactions means altering expression of one gene affects the expression of the other; Physical interaction means that product interact in a protein interaction study; Shared protein domain means that proteins produced by the gene are part of the same protein, enzyme or complex.
The genetic influence on each other is less and also has very less existence in cells and Promotes the malignant progression of breast cancer (Jiang et al. 2015 Inhibits the proliferation of breast cancer cells (Cai et al. 2016) tissues. Collectively all predicted target genes for has-mir-27a-3p had co-expression 49.74 percent, predicted 25.20 percent, pathway 18.36 percent, physical interactions 5.02 percent, colocalization 1.40 percent, and shared protein domains 0.28 percent. The 27a-3p predicted target genes showed a 49.7 percent similar expression, while they tend to have a lower tendency of becoming part of a protein domain. However, they are involved in the regulation of different pathways sharing 25.2 percent of reactions involved in various pathways. These genes are less affected by perturbation from one another (Table 4) .
hsa-mir-27a-5p Target Predicted Genes Network
Co-expression 39.46 percent, pathway 32.06 percent, physical interactions 16.08 percent, predicted 7.83 percent, co-localization 4.16 percent, genetic interactions 0.41 percent. For the 27a-5p targets the co-expression rate is 39.46 percent, next comes involvement in pathways and there is very less genetic interaction predicted for them (Table 4) .
hsa-mir-27a-3p and 27a-5p Combined Targets Interactions
Predicted 45.01 percent, co-expression 31.48 percent, pathway 16.30 percent, physical interactions 4.56 percent, genetic interactions 1.88 percent, shared protein domains 0.46 percent and co-localization 0.31 percent. When all the predicted target genes are co-analyzed it is observed that the co-expression of these genes is reduced to 31.48 percent. They do not express in the same tissues or cells and share protein domains in a very small percentage (Table 4) .
DISCUSSION
Only those predicted genes were enlisted which were predicted by at least 6 target prediction tools. For hsa-mir-27a-3p a total of 51 target genes were found while for has-mir-27a-5p; 45 targets were determined. The genes were explored for their role in breast cancer using the online available literature. It was found that the target genes are involved in vital processes that regulate the formation and development of tumors. Nine genes, that are predicted targets of hsa-mir-27a, have been reported to be downregulated in breast cancer patients such as NKAIN1 and PIK3CA mutated breast tumors and STARD7 in human breast adenocarcinoma MCF cells and HIVEP3, ZBTB4, and KCNA1 in breast and other human cancer. Besides breast cancer tumor aggression in gastric cancer is increased by mutations PIK3CA (Kim et al. 2017) . FBXW7 has been reported to have reduced mRNA level in breast cancer cells as compared to normal tissues, similarly, FBXW7 disruption increased cancer progression by suppressing apoptosis and promoting cell proliferation in breast cancer cells (Xia et al. 2017) . In another study it is been stated that inhibition of FBXW7 by mir-367a promoted tumor growth in breast cancer patients (Xiao et al. 2017) while IQGAP2 has lower expression in breast tissues and higher stages of breast cancer and is associated with survival of breast cancer patients (Kumar et al. 2017; Wei et al. 2012) .
The expression levels of CLTCL1 are reduced during breast cancer early invasiveness and SMAD4 has been reported to be down-regulated in ductal breast carcinomas. This gene has been identified as a driver mutation of tumorigenesis in dendritic cell carcinoma (Davila et al. 2017) . In contrast to down-regulated genes; cer- (Binothman et al. 2017; Zhang et al. 2017; Velasco-Velázquez et al. 2014; Andres et al. 2013; Li et al. 2002; Monni et al. 2001; Ottenhoff-Kalff et al. 1995) . Similarly, variable expression for EDEM3 has been reported in breast carcinomas (Potapenko et al. 2015) . Significantly high regulation of BRF3 in basal-like BRCA1, NRID2 in adipose tissue and (DLL4 and ANTXR1) in tumor vasculature have been known in previous research work (Andersen et al. 2016; Prat et al. 2014; Sainson and Harris 2007; Preitne et al. 2002) . ANTXR1 has been used as a member in targeted therapy against triple negative breast cancer treatment in recent studies (Byrd et al. 2017) .
Increased expression of PPAT in lung cancer and BTF3 in other epithelial carcinomas was found in two separate studies (Goswami et al. 2015; Symes et al. 2013) . Two independent studies have reported overexpression of PRX in breast cancer tissues as compared to other tissue cells and cancers. In addition, PRKCB and DLL4 are involved in angiogenesis. PRKCB has been reported to be a good predictor for nonsmall cell lung cancer (NSCLC) in recent research .
Previous investigations have shown that WNK3 suppression accelerated the apoptotic response in HELA cells. Griner and Kazanietz (2007) have reported the involvement of PRKCB in apoptosis while TMEM33 induced apoptosis in breast cancer when overexpressed (Clarke et al. 2017) . PLK2 and SMARCA1 regulated mitotic spindle orientation and remodeling while STAB2 is responsible regulation of gene expression besides chromatin remodeling. PLK2 down-regulation has been reported in other cancer like Bcell neoplasm (Syed et al. 2006 ). Cell survival is hallmark of cancerous cells. The predicted target gene WNK3, ABACA1, and CDC42BPB are reported to promote cell survival. In different cellular contexts, NGFR acts either as a tumor suppressor or an oncogene. FGD6 depletion reduced the process of colony formation in MCF10A cells, SRL, FBXW7, and MYOD1 inhibits proliferation of breast cancer cells and negatively regulates different oncoproteins (Cai et al. 2016; Savanur et al. 2014; Welcker et al. 2004) . NRID2 is oncosuppressor in breast cancer and NOTCH2 in colorectal cancer (Garattini et al. 2016; Chu et al. 2011) . ZBTB4, PSD2, UFL1, and PPP2R2 are a tumor suppressor in breast cancer cells and early loss of PSD2 contributes to the progression of breast cancer. SLC23A helps in autophagy of breast cancer cells.
PAX9 potentially play important role in tumorigenesis and proliferation. PLK2 loss leads to increased mammary epithelial cell proliferation and ductal hyper-branching, inhibition or depletion of TAOK1 increases the mitotic population of cells (Koo et al. 2017) . EIF5, CCR5, and SOWAHA overexpression are associated with an increase in metabolic activity and breast cancer cell proliferation (Gao et al. 2016; Imaoka et al. 2014; Homma et al. 2005) . ELAVL1 increased at all stages of breast cancers and promotes breast cancer cell proliferation and invasion Gubin et al. 2010) . EIF1AX over-expression results in cell proliferation, PAF1 regulates cell cycle and PRKCA overexpression reduces proliferation and migration of breast cancer cells.
Overexpression of LPCAT1 and down-regulation of PAX9 contributes to breast cancer progression and malignancy. CKAP4 is significantly correlated with tumor size. KATNBL1, C6orf106, TEAD1, and EN2 contribute to tumor progression in breast, hepatocellular and colorectal cancer (Oh et al. 2016; Zhou et al. 2016b; Jiang et al. 2015; Martin et al. 2005) . EYA1 enhanced tumor growth in mice in vivo requiring the phosphatase domain. MAG13 promotes malignant transformation of human mammary epithelial cells (Ni and Kuperwasser 2016) . TMSB10 regulates tumorigenesis and metastasis . PCDH20 and PRKCA significantly suppress migration and tumor formation in hepatocellular and breast cancer cells. NR4A1 promotes breast cancer invasion and metastasis. SERPINB7 and NAPA suppress the invasion and motility of malignant cancer cell. CPSF2 and PAF1 promote tumor (Binothman et al. 2017; Chaudhary et al. 2007) . PTP4A2 promotes breast tumor formation in the mouse model. ORC5 is involved in the regulation of cell cycle and DNA replication. NR1D2 regulates cell metabolism and thermogenic responses, depletion SMARCA1 promotes cancer cell growth while PPP1CC interacts with BRCA1 gene.
CONCLUSION
Matured miRNAs (hsa-mir-27a-3p and hsamir-27a-5p) codded by MIR27a gene regulates several genes in the human genome that are associated with breast cancer. Deregulation of MIR27a gene due to mutation may affect the functions of these predicted target genes. Experimental validation of interaction between the target genes and hsa-mir-27a-3p/5p can help in better understanding the initiation, proliferation, tumorigenesis, and metastasis in breast cancer.
RECOMMENDATIONS
Further in-vitro study is required to investigate the interaction of miR-27a gene with predicted cancer-associated genes reported in the current study.
